220 related articles for article (PubMed ID: 9438869)
1. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
Martin PD; Malkowski MG; Box J; Esmon CT; Edwards BF
Structure; 1997 Dec; 5(12):1681-93. PubMed ID: 9438869
[TBL] [Abstract][Full Text] [Related]
2. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Biochemistry; 1993 May; 32(18):4727-37. PubMed ID: 8387813
[TBL] [Abstract][Full Text] [Related]
3. Structure of the non-covalent complex of prothrombin kringle 2 with PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Chem Phys Lipids; 1994 Jan; 67-68():59-66. PubMed ID: 8187245
[TBL] [Abstract][Full Text] [Related]
4. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
5. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
Bode W; Turk D; Karshikov A
Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
[TBL] [Abstract][Full Text] [Related]
6. Calcium ion modulation of meizothrombin autolysis at Arg55-Asp56 and catalytic activity.
Stevens WK; Côté HF; MacGillivray RT; Nesheim ME
J Biol Chem; 1996 Apr; 271(14):8062-7. PubMed ID: 8626490
[TBL] [Abstract][Full Text] [Related]
7. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin.
Petrovan RJ; Govers-Riemslag JW; Nowak G; Hemker HC; Tans G; Rosing J
Biochemistry; 1998 Feb; 37(5):1185-91. PubMed ID: 9477942
[TBL] [Abstract][Full Text] [Related]
8. Na+ binding to meizothrombin desF1.
Papaconstantinou ME; Gandhi PS; Chen Z; Bah A; Di Cera E
Cell Mol Life Sci; 2008 Nov; 65(22):3688-97. PubMed ID: 18854941
[TBL] [Abstract][Full Text] [Related]
9. The in situ inhibition of prothrombinase-formed human alpha-thrombin and meizothrombin(des F1) by antithrombin III and heparin.
Schoen P; Lindhout T
J Biol Chem; 1987 Aug; 262(23):11268-74. PubMed ID: 3611110
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin.
Taneda H; Andoh K; Nishioka J; Takeya H; Suzuki K
J Biochem; 1994 Sep; 116(3):589-97. PubMed ID: 7852276
[TBL] [Abstract][Full Text] [Related]
11. Evidence that meizothrombin is an intermediate product in the clotting of whole blood.
Bovill EG; Tracy RP; Hayes TE; Jenny RJ; Bhushan FH; Mann KG
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):754-8. PubMed ID: 7773729
[TBL] [Abstract][Full Text] [Related]
12. Crystallographic evidence that the F2 kringle catalytic domain linker of prothrombin does not cover the fibrinogen recognition exosite.
van de Locht A; Stubbs MT; Bauer M; Bode W
J Biol Chem; 1996 Feb; 271(7):3413-6. PubMed ID: 8631941
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence resonance energy transfer study of shape changes in membrane-bound bovine prothrombin and meizothrombin.
Chen Q; Lentz BR
Biochemistry; 1997 Apr; 36(15):4701-11. PubMed ID: 9109682
[TBL] [Abstract][Full Text] [Related]
14. The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding.
Malkowski MG; Martin PD; Guzik JC; Edwards BF
Protein Sci; 1997 Jul; 6(7):1438-48. PubMed ID: 9232645
[TBL] [Abstract][Full Text] [Related]
15. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation.
Rosing J; Zwaal RF; Tans G
J Biol Chem; 1986 Mar; 261(9):4224-8. PubMed ID: 3753979
[TBL] [Abstract][Full Text] [Related]
16. The active site of membrane-bound meizothrombin. A fluorescence determination of its distance from the phospholipid surface and its conformational sensitivity to calcium and factor Va.
Armstrong SA; Husten EJ; Esmon CT; Johnson AE
J Biol Chem; 1990 Apr; 265(11):6210-8. PubMed ID: 2180944
[TBL] [Abstract][Full Text] [Related]
17. Probing prothrombin structure by limited proteolysis.
Acquasaliente L; Pelc LA; Di Cera E
Sci Rep; 2019 Apr; 9(1):6125. PubMed ID: 30992526
[TBL] [Abstract][Full Text] [Related]
18. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
Anderson PJ; Bock PE
J Biol Chem; 2003 Nov; 278(45):44489-95. PubMed ID: 12939270
[TBL] [Abstract][Full Text] [Related]
19. Localization of the thrombin-binding domain on prothrombin fragment 2.
Liaw PC; Fredenburgh JC; Stafford AR; Tulinsky A; Austin RC; Weitz JI
J Biol Chem; 1998 Apr; 273(15):8932-9. PubMed ID: 9535876
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation.
Friedrich R; Panizzi P; Kawabata S; Bode W; Bock PE; Fuentes-Prior P
J Biol Chem; 2006 Jan; 281(2):1188-95. PubMed ID: 16230338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
